• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 12220
Device Problems Material Discolored (1170); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/10/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that 3/4 of the way through a therapeutic plasma exchange (tpe) procedure on a patient with demyelinating disease and multiple sclerosis, they began seeing red tinged plasma going up to the remove bag and in the connector.Per the customer, the plasma was a typical yellow-tinged color at the start of the procedure and the hemolysis was not due to disease state or medication given.The operator had already disabled the rbc detector before contacting terumo bct as they had done this before on other procedures and thought this would resolve the issue.Per physician's order, the procedure was ended, and no medical intervention was necessary.The patient is reported as stable.The patient was an in-patient, so they decided to check the patient's cbc the following day, as already planned, and repeat the procedure the following monday, as already planned.The customer declined to provide the patient identifier.The exchange set was disposed of and is not available for return.
 
Manufacturer Narrative
This report is being filed to provide additional information in e.3, h.6, and h.10.Investigation: the device history record (dhr) was reviewed for this lot.There were no issues noted in the dhr that would have contriubted to the red-tinged plasma as experienced by the customer.Root cause: a definitive root cause for the discolored plasma could not be determined.Possible causes include but are not limited to: a misload of the disposable set.An unidentified manufacturing defect in the disposable set.A partially open inlet line clamp.An issue with the patient's catheter (defect or misplacement).An issue with the replacement albumin fluid.An issue with the ac solution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key9660510
MDR Text Key186021146
Report Number1722028-2020-00044
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 02/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/01/2021
Device Catalogue Number12220
Device Lot Number1911123130
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 01/10/2020
Initial Date FDA Received02/03/2020
Supplement Dates Manufacturer Received05/15/2020
Supplement Dates FDA Received06/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00044 YR
Patient Weight79
-
-